癌症免疫学与免疫疗法：影响抗肿瘤免疫反应及治疗抗性的机制
Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment Resistance.
作者信息
Zhao Xianda, Subramanian Subbaya
机构信息
Department of Surgery, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
出版信息
Cancers (Basel). 2021 Nov 12;13(22):5655. doi: 10.3390/cancers13225655.
Abstract
The past decade has seen immunotherapy rise to the forefront of cancer treatment [...].
摘要
在过去十年中，免疫疗法已成为癌症治疗的前沿手段[...]。
相似文献
1
Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment Resistance.癌症免疫学与免疫疗法：影响抗肿瘤免疫反应及治疗抗性的机制
Cancers (Basel). 2021 Nov 12;13(22):5655. doi: 10.3390/cancers13225655.
2
The importance of animal models in tumor immunity and immunotherapy.动物模型在肿瘤免疫和免疫治疗中的重要性。
Curr Opin Genet Dev. 2014 Feb;24:46-51. doi: 10.1016/j.gde.2013.11.008. Epub 2013 Dec 29.
3
Tuberculosis-Cancer Parallels in Immune Response Regulation.结核病-癌症免疫反应调控的相似性。
Int J Mol Sci. 2020 Aug 26;21(17):6136. doi: 10.3390/ijms21176136.
4
Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy.肿瘤微环境中的新兴免疫检查点：对癌症免疫治疗的影响。
Cancer Lett. 2021 Jul 28;511:68-76. doi: 10.1016/j.canlet.2021.04.021. Epub 2021 May 3.
5
The Future of Immunotherapy: A 20-Year Perspective.免疫疗法的未来：20年展望。
Front Immunol. 2017 Nov 28;8:1668. doi: 10.3389/fimmu.2017.01668. eCollection 2017.
6
Recent advances in cancer immunology and immunology-based anticancer therapies.癌症免疫学和基于免疫学的抗癌疗法的最新进展。
Biomed Pharmacother. 2017 Dec;96:1491-1500. doi: 10.1016/j.biopha.2017.11.126. Epub 2017 Dec 2.
7
Immune-checkpoint blockade and active immunotherapy for glioma.免疫检查点阻断和主动免疫疗法治疗神经胶质瘤。
Cancers (Basel). 2013 Nov 1;5(4):1379-412. doi: 10.3390/cancers5041379.
8
Tracking cellular and immune therapies in cancer.追踪癌症中的细胞和免疫疗法。
Adv Cancer Res. 2014;124:257-96. doi: 10.1016/B978-0-12-411638-2.00008-2.
9
Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.自然杀伤细胞：癌症免疫治疗成功的关键。
Front Immunol. 2021 Apr 28;12:679117. doi: 10.3389/fimmu.2021.679117. eCollection 2021.
10
The development of new cancer therapies based on the molecular identification of cancer regression antigens.基于癌症消退抗原分子鉴定的新型癌症治疗方法的开发。
Cancer J Sci Am. 1995 Jul-Aug;1(2):90-100.
引用本文的文献
1
Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications.推进癌症免疫疗法：从分子机制到临床应用。
Cancers (Basel). 2023 Aug 21;15(16):4197. doi: 10.3390/cancers15164197.
2
Editorial: Bioinformatics tools (and web server) for cancer biomarker development, volume II.社论：用于癌症生物标志物开发的生物信息学工具（及网络服务器），第二卷。
Front Genet. 2022 Oct 10;13:959159. doi: 10.3389/fgene.2022.959159. eCollection 2022.
本文引用的文献
1
Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T Cells.结直肠癌患者肿瘤和结肠中的抗原呈递细胞在激活和功能状态上存在差异，但对活化T细胞的反应相当。
Cancers (Basel). 2021 Oct 19;13(20):5247. doi: 10.3390/cancers13205247.
2
Involvement of Kynurenine Pathway in Hepatocellular Carcinoma.犬尿氨酸途径在肝细胞癌中的作用
Cancers (Basel). 2021 Oct 15;13(20):5180. doi: 10.3390/cancers13205180.
3
ACKR4 in Tumor Cells Regulates Dendritic Cell Migration to Tumor-Draining Lymph Nodes and T-Cell Priming.肿瘤细胞中的ACKR4调节树突状细胞向肿瘤引流淋巴结的迁移及T细胞启动。
Cancers (Basel). 2021 Oct 7;13(19):5021. doi: 10.3390/cancers13195021.
4
Facile Generation of Potent Bispecific Fab via Sortase A and Click Chemistry for Cancer Immunotherapy.通过分选酶A和点击化学简便生成用于癌症免疫治疗的强效双特异性Fab片段
Cancers (Basel). 2021 Sep 10;13(18):4540. doi: 10.3390/cancers13184540.
5
Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation.肿瘤微环境：三阴性乳腺癌免疫调节中的关键因素
Cancers (Basel). 2021 Jul 4;13(13):3357. doi: 10.3390/cancers13133357.
6
Systemic Treatment Initiation in Classical and Endemic Kaposi's Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study.经典型和地方性卡波西肉瘤的全身治疗起始：单中心队列研究中的风险因素及全球多状态建模
Cancers (Basel). 2021 May 21;13(11):2519. doi: 10.3390/cancers13112519.
7
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma.如何使免疫疗法成为葡萄膜黑色素瘤的有效治疗选择。
Cancers (Basel). 2021 Apr 23;13(9):2043. doi: 10.3390/cancers13092043.
8
Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma.重组人IL15蛋白与白蛋白结合域融合对结肠癌和黑色素瘤抗PD-L1免疫治疗效率及抗肿瘤免疫的临床前评估
Cancers (Basel). 2021 Apr 9;13(8):1789. doi: 10.3390/cancers13081789.
9
Tumor-Secreted Extracellular Vesicles Regulate T-Cell Costimulation and Can Be Manipulated To Induce Tumor-Specific T-Cell Responses.肿瘤分泌的细胞外囊泡调节 T 细胞共刺激，并可被操纵以诱导肿瘤特异性 T 细胞反应。
Gastroenterology. 2021 Aug;161(2):560-574.e11. doi: 10.1053/j.gastro.2021.04.036. Epub 2021 Apr 23.
10
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy.用于癌症免疫治疗的调节性T细胞中的CTLA-4
Cancers (Basel). 2021 Mar 22;13(6):1440. doi: 10.3390/cancers13061440.
Zotero 插件